The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Discuss the relevant practice changing results from recent clinical studies for patients with advanced or recurrent endometrial cancer.
Describe approaches for treatment decision-making based on recent clinical trial results on molecular characterization of endometrial cancer.
Review the strategies to prioritize and sequence the first-line and second/subsequent-line therapy options recommended in the NCCN Guidelines® for Uterine Neoplasms.